α-tocopherol suppresses mammary tumor sensitivity to anthracyclines in fish oil-fed rats

Nutrition and Cancer

Volumn 51, Issue 2, 2005, Pages 178-183

  Colas, Séverine ^a   Germain, Emmanuelle ^a   Arab, Khelifa ^b   Maheo, Karine ^a   Goupille, Caroline ^a   Bougnoux, Philippe ^a,c  

^a CHU BRETONNEAU   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; DEHYDROASCORBIC ACID; EPIRUBICIN; FISH OIL; METHYLNITROSOUREA; NAPHTHOQUINONE; OMEGA 3 FATTY ACID; OXIDIZING AGENT; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER CELL CULTURE; CHEMOSENSITIVITY; CONTROLLED STUDY; DIET; DRUG CYTOTOXICITY; DRUG EFFICACY; FEMALE; IN VIVO STUDY; INJECTION; LIPID PEROXIDATION; NONHUMAN; RAT; SENSITIZATION; TUMOR VOLUME;

ADIPOSE TISSUE; ALPHA-TOCOPHEROL; ANIMALS; ANTHRACYCLINES; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; CARCINOGENS; DIET; DISEASE MODELS, ANIMAL; DRUG ANTAGONISM; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; FATTY ACIDS, UNSATURATED; FEMALE; FISH OILS; MALONDIALDEHYDE; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; OXIDANTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 19544375576     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5102_8     Document Type: Article

References (44)

1. Bougnoux P: n-3 polyunsaturated fatty acids and cancer. Curr Opin Clin Nutr Metab Care 2, 121-126, 1999.
2. Burns P and Spector AA: Biochemical effects of lipids on cancer therapy. J Nutr Biochem 5, 114-123, 1994.
3. Sagar S and Das UN: Gamma linolenic acid and eicosapentaenoic acid potentiate the cytotoxicity of anticancer drugs on human cervical carcinoma (He La) cells in vitro. Med Sci Res 21, 457-459, 1993.
4. Tsai WS, Nagawa H, and Muto T: Differential effects of polyunsaturated fatty acids on chemosensitivity of NIH3T3 cells and its transformants. Int J Cancer 70, 361-367, 1997.
5. Germain E, Chajes V, Cognault S, Lhuillery C, and Bougnoux P: Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int J Cancer 75, 578-583, 1998.
6. Kinsella JE and Black JM: Effect of polyunsaturated fatty acids on the efficacy of antineoplastic agents toward L5178Y lymphoma cells. Biochem Pharmacol 45, 1881-1887, 1993.
7. Shao Y, Pardini L, and Pardini RS: Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1. Lipids 30, 1035-1045, 1995.
8. Borgeson C, Pardini L, Pardini R, and Reitz R: Effects of dietary fish oil on human mammary carcinoma and lipid-metabolizing enzymes. Lipids 24, 290-295, 1989.
9. Shao Y, Pardini L, and Pardini RS: Enhancement of the antineoplastic effect of mitomycin C by dietary fat. Cancer Res 54, 6452-6457, 1994.
10. Germain E, Lavandier F, Chajes V, Schubnel V, Bonnet P, et al.: Dietary n-3 polyunsaturated fatty acids and oxidants increase rat mammary tumor sensitivity to epirubicin without change in cardiac toxicity. Lipids 34, S203, 1999.
11. Hardman WE, Avula CP, Fernandes G, and Cameron IL: Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin Cancer Res 7, 2041-2049, 2001.
12. Bougnoux P, Germain E, Chajes V, Hubert B, Lhuillery C, et al.: Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma. Br J Cancer 79, 1765-1769, 1999.
13. Hawkins RA, Sangster K, and Arends MJ: Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 185, 61-70, 1998.
14. Begin ME, Ells G, and Horrobin DF: Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. JNCI 80, 188-194, 1988.
15. Colas S, Paon L, Denis F, Prat M, Louisot P, et al.: Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid. Int J Cancer 109, 449-454, 2004.
16. Cognault S, Jourdan ML, Germain E, Pitavy R, Morel E, et al.: Effect of an α-linolenic acid-rich diet on rat mammary tumor growth depends on the dietary oxidative status. Nutr Cancer 36, 33-41, 2000.
17. Potier de Courcy G, Durand G, Abraham J, and Guegen L: Recommendations sur les conditions d'alimentation des animaux de laboratoire (rats et souris). Sci Aliment 9, 209-217, 1989.
18. Noto V, Taper HS, Yi-Hua J, Janssens J, Bonte J, et al.: Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. Synergism of combined vitamin C and K3 action. Cancer 63, 901-906, 1989.
19. Bougnoux P, Koscielny S, Chajes V, Descamps P, Couet C, et al.: Alpha-linolenic acid content of adipose breast tissue: a host determinant of the risk of early metastasis in breast cancer. Br J Cancer 70, 330-334, 1994.
20. Folch J, Lees M, and Stanley GH: A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226, 497-509, 1957.
21. Maillard V, Bougnoux P, Ferrari P, Jourdan ML, Pinault M, et al.: N-3 and n-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Int J Cancer 98, 78-83, 2002.
22. Bligh EG and Dyer WJ: A rapid method of total lipid extraction and purification. Can J Med Sci 37, 911-917, 1959.
23. Hatam LJ and Kayden HJ: A high-performance liquid chromatographic method for the determination of tocopherol in plasma and cellular elements of the blood. J Lipid Res 20, 639-645, 1979.
24. Steghens JP, van Kappel AL, Denis I, and Collombel C: Diaminonaphthalene, a new highly specific reagent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum. Free Radic Biol Med 31, 242-249, 2001;
25. Erratum in Free Radic Biol Med 32, 299, 2002.
26. Shao Y, Pardini L, and Pardini RS: Intervention of transplantable human mammary carcinoma MX-1 chemotherapy with dietary menhaden oil in athymic mice: increased therapeutic effects and decreased toxicity of cyclophosphamide. Nutr Cancer 28, 63-73, 1997.
27. Cha MC, Meckling KA, and Stewart C: Dietary docosahexaenoic acid levels influence the outcome of arabinosylcytosine chemotherapy in L1210 leukemic mice. Nutr Cancer 44, 176-181, 2002.
28. Harris NM, Anderson WR, Lwaleed BA, Cooper AJ, Birch BR, et al.: Epirubicin and meglumine gamma-linolenic acid: a logical choice of combination therapy for patients with superficial bladder carcinoma. Cancer 91, 71-82, 2003.
29. Jiang WG, Bryce RP, and Horrobin DF: Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. Crit Rev Oncol Hematol 27, 179-209, 1998.
30. Chow SC, Sisfontes L, Bjorkhem I, and Jondal M: Suppression of growth in a leukemic T cell line by n-3 and n-6 polyunsaturated fatty acids. Lipids 24, 700-704, 1989.
31. Chajes V, Sattler W, Stranzl A, and Kostner GM: Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin E. Breast Cancer Res Treat 34, 199-212, 1995.
32. Menendez JA, Del Mar Barbacid M, Montero S, Sevilla E, Escrich E, et al.: Effects of gamma-linolenic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer 37, 402-413, 2001.
33. Shen HM, Yang CF, Ding WX, Liu J, and Ong CN: Superoxide radical-initiated apoptotic signalling pathway in selenite-treated HepG2 cells: mitochondria serve as the main target. Free Radic Biol Med 30, 9-21, 2001.
34. Slater AFG, Nobel CSI, and Orrenius S: The role of intracellular oxidants in apoptosis. Biochim Biophys Acta 1271, 59-62, 1995.
35. Williams MS and Kwon JT: Cell receptor stimulation, reactive oxygen species, and cell signaling. Free Radic Biol Med 37, 1144-1151, 2004.
36. Kamata H and Hirata H: Redox regulation of cellular signalling. Cell Signal 1, 1-14, 1999.
37. Klotz LO, Patak P, Ale-Agha N, Buchczyk DP, Abdelmohsen K, et al.: 2-Methyl-1,4-naphthoquinone, vitamin K(3), decreases gap-junctional intercellular communication via activation of the epidermal growth factor receptor/extracellular signal-regulated kinase cascade. Cancer Res 62, 4922-4928, 2004.
38. Abdelmohsen K, Gerber PA, von Montfort C, Sies H, and Klotz LO: Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: role of glutathione and tyrosine phosphatases. J Biol Chem 278, 38360-38367, 2003.
39. Rimbach G, Minihane AM, Majewicz J, Fischer A, Pallauf J, et al.: Regulation of cell signalling by vitamin E. Proc Nutr Soc 61, 415-425, 2004.
40. Azzi A, Gysin R, Kempna P, Munteanu A, Villacorta L, et al.: Regulation of gene expression by alpha-tocopherol. Biol Chem 385, 585-591, 2004.
41. Jiang Q and Ames BN: Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J 17, 816-822, 2003.
42. Cooney RV, Franke AA, Harwood PJ, Hatch-Pigott V, Custer LJ, et al.: Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc Natl Acad Sci USA 90, 1771-1775, 1993.
43. Campbell S, Stone W, Whaley S, and Krishnan K: Development of gamma (γ)-tocopherol as a colorectal cancer chemopreventive agent. Crit Rev Oncol Hematol 47, 249-259, 2003.
44. Liu Q-Y and Tan BKH: Dietary fish oil and vitamin E enhance doxorubicin effects in P388 tumor-bearing mice. Lipids 37, 549-556, 2002.